The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ovarian cancer (OC) assessment has been proposed. We compared the clinical value of biomarker changes in a prospective series of patients undergoing OC monitoring.
Serum human epididymis protein 4 vs. carbohydrate antigen 125 in ovarian cancer follow-up
Paganoni, Anna Maria;
2018-01-01
Abstract
The addition of human epididymis protein 4 (HE4) to carbohydrate antigen 125 (CA125) in ovarian cancer (OC) assessment has been proposed. We compared the clinical value of biomarker changes in a prospective series of patients undergoing OC monitoring.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CB_Sacco_2018.pdf
Accesso riservato
Dimensione
482.19 kB
Formato
Adobe PDF
|
482.19 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
